Diamyd Medical AB (publ) (STO:DMYD.B)
Sweden · Delayed Price · Currency is SEK 1.090
+0.020 (1.87%)
Jul 3, 2026, 5:29 PM CET
Diamyd Medical AB Market Cap
Diamyd Medical AB has a market cap or net worth of 168.93 million as of July 2, 2026. Its market cap has decreased by -87.31% in one year.
Market Cap
168.93M
Enterprise Value
-177.17M
Revenue
432.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
1.09
Market Cap Chart
Since May 20, 2013, Diamyd Medical AB's market cap has increased from 132.51M to 168.93M, an increase of 27.48%. That is a compound annual growth rate of 1.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 168.93M | -89.09% |
| Dec 30, 2025 | 1.55B | -9.52% |
| Dec 30, 2024 | 1.71B | 182.47% |
| Dec 29, 2023 | 605.80M | -41.10% |
| Dec 30, 2022 | 1.03B | -9.66% |
| Dec 30, 2021 | 1.14B | -46.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Isofol Medical AB | 259.60M |
| Xbrane Biopharma AB | 222.54M |
| Elicera Therapeutics AB | 195.54M |
| IRLAB Therapeutics AB | 195.41M |
| Initiator Pharma | 190.98M |
| Xintela AB | 175.70M |
| Nanologica AB | 163.07M |
| Active Biotech AB | 148.41M |